摘要
弥漫性大B细胞淋巴瘤(DLBCL)是发病率较高的淋巴造血系统疾病,该病进展较快、病死率较高。如何通过现有的检查技术精确地对患者进行预后评估是研究者们面临的一大难题。目前,PET/CT以其能同时提供解剖及功能图像的独特优势,广泛地应用于淋巴瘤的治疗监测及预后评估中,但采用哪种评价体系对图像进行判读的准确率更高仍存在较大争议。笔者综述了PET/CT定性、半定量及其他新的评价体系在DLBCL预后评估中的应用价值。
Diffuse large B-cell lymphoma is a hematopoietic system disease with high incidence rate,rapid progression,and high mortality rate.Accurate prognosis evaluation through existing examination techniques is a major problem faced by scholars.At present,PET/CT has been widely used in the treatment monitoring and prognosis evaluation of lymphomas because of its unique advantage of simultaneously providing anatomical and functional images.However,a major controversy persists about which evaluation system provides accurate image assessment.This paper mainly introduces the application value of qualitative,semi-quantitative,and other new evaluation systems in the prognosis evaluation of diffuse large-B cell lymphoma.
作者
李梦丹
敬兴果
Li Mengdan;Jing Xingguo(Department of Nuclear Medicine,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处
《国际放射医学核医学杂志》
2020年第2期99-104,共6页
International Journal of Radiation Medicine and Nuclear Medicine
